ASX:PKYSoftware & ServicesApplication Software
Pathkey.AI Ltd
$0.058
$0.004 (6.45%)
Day Range
$0.057 – $0.065
52 Week Range
$0.013 – $0.075
Volume
8.06M
Avg Volume (10D)
7.51M
Market Cap
$69.85M
Price Chart
Market Statistics
Open$0.063
Previous Close$0.062
Day High$0.065
Day Low$0.057
52 Week High$0.075
52 Week Low$0.013
Valuation
Market Cap69.85M
Shares Outstanding1.20B
Price to Book41.85
Trading Activity
Volume8.06M
Value Traded478.90K
Bid$0.058 × 1,992,216
Ask$0.059 × 123,696
Performance
1 Day-6.06%
5 Day-12.68%
13 Week181.82%
52 Week127.15%
YTD287.50%
Technical Indicators
RSI (14)52.29
50-Day SMA$0.049
200-Day SMA$0.028
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]